VSTM
NASDAQ · Biotechnology
Verastem Inc
$4.86
-0.80 (-14.13%)
Open$5.68
Previous Close$5.66
Day High$5.68
Day Low$4.85
52W High$11.25
52W Low$4.01
Volume—
Avg Volume1.92M
Market Cap492.23M
P/E Ratio—
EPS$-2.13
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+189.1% upside
Current
$4.86
$4.86
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 45.17M | 14.27M | 326.86M |
| Net Income | -306,102,461 | -167,775,411 | 9.66M |
| Profit Margin | -677.6% | -1,241.1% | 3.0% |
| EBITDA | -310,386,660 | -176,249,033 | 19.14M |
| Free Cash Flow | — | — | 10.52M |
| Rev Growth | +128.2% | +69.6% | +8.0% |
| Debt/Equity | 1.51 | 0.51 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |